Alison Holland
Chief Customer Officer, Medable
Alison Holland
Chief Customer Officer, Medable
Innes Meldrum
CEO, AdhereTech
Innes Meldrum
CEO, AdhereTech
Product: Aidia System
Company: AdhereTech
About the Product:
AdhereTech's Aidia system addresses one of the biggest unsolved problems in public health: medication non-adherence. Using real time, cellular connected smart devices - no phones or apps required - Aidia fits seamlessly into patients daily routines. By applying behavioral health principals and stepping in to resolve adherence barriers, we enable patients to receive the fullest benefit intended by their doctors. In both clinical trials and commercial settings, the Aidia System consistently increases adherence and persistence, reduces the risk of trial failure, improves pharmaceutical margins, lowers avoidable healthcare costs, and ultimately improves patient outcomes.
Ricardo Lopez Barquilla
Co-Founder & Technical Advisor, All4Cure, Inc.
Ricardo Lopez Barquilla
Co-Founder & Technical Advisor, All4Cure, Inc.
Product: All4Cure Platform
Company: All4Cure, Inc.
About the Product:
All4Cure is a digital health platform transforming cancer care through collaborative intelligence. It connects patients, oncologists, and researchers in real time to discuss complex cases, accelerate clinical trial enrollment, and generate high-quality real-world evidence. Patients securely contribute their medical records and consent to data sharing, enabling precision treatment and rapid research insights. Unlike EMRs or tumor boards, All4Cure is dynamic, patient-inclusive, and built for scale. With a focus on relapsed and rare cancers like multiple myeloma, the platform empowers expert-informed decisions while building a continuously learning, ethically sourced knowledge base to advance cancer care worldwide.
Romain Marmot
President, Aptar Digital Health
Romain Marmot
President, Aptar Digital Health
Product: Migraine Buddy's Weather and Trigger Advanced Reports
Company: Aptar Digital Health
About the Product:
Migraine Buddy is a mobile application developed by Aptar Digital Health, a global leader in digital health, and part of AptarGroup, Inc. Migraine Buddy was first launched in 2014 and aims to empower patients suffering from headaches and migraine through data-driven insights. Migraine Buddy quickly gained traction among migraine sufferers due to its user-friendly design and comprehensive tracking capabilities, allowing them to track their symptoms and triggers easily. The app's success attracted significant attention, leading to partnerships with headache and research institutions. Over the past 10 years, Migraine Buddy has become the number one mobile application for tracking headaches and migraines. Recommended by the world's leading neurologists, it enables migraine sufferers to learn and better communicate about their headaches. Our community of 4+ million users across 132 countries contributes to migraine awareness and research. Migraine affects 1 in 7 people worldwide, with only 60% having access to treatment.
Vada Perkins
Vice President, Global Head of Regulatory Intelligence & Policy, Boehringer Ingelheim
Vada Perkins
Vice President, Global Head of Regulatory Intelligence & Policy, Boehringer Ingelheim
Product: Project PRISM/Project CRYPTx
Company: DNAnexus + Boehringer Ingelheim Joint Submission
About the Product:
Together, DNAnexus and Boehringer Ingelheim delivered a secure, cloud-based integration of regulatory workflows connecting DNAnexus’ Trusted Regulatory Spaces, Boehringer’s internal RIM systems, and precisionFDA. The scalable, interoperable platform enables evidence generation, governance, and data exchange through a “submit once, review together” model supporting multi agency reliance and work-sharing. Built-in security, computer system validation, and provenance tracking ensure compliance, data integrity, and reproducibility. By enabling secure collaboration and democratized access to regulatory resources, the platform advances global regulatory stakeholder interaction and efficiency in the cloud.
James Min
Founder and CEO, Cleerly
James Min
Founder and CEO, Cleerly
Product: Cleerly Labs
Company: Cleerly
About the Product:
GlucoseReady is a novel, fully integrated GCP eClinical platform designed to optimize patient engagement and retention for cardiometabolic areas including diabetes and chronic weight management. It includes a full suite of eCOA capabilities that can address capture of both active patient diaries and passive wearables and complex sensor data. This includes a range of connected CGM and BGM devices. The implementation of AI algorithms are designed to improve patient outcomes and enhance safety surveillance. We believe this unique tool represents the new gold standard for retention and data capture in the new era of GLP-1 cardiometabolic clinical trials.
Omar Serang
Chief Cloud Officer, DNAnexus
Omar Serang
Chief Cloud Officer, DNAnexus
Product: Project PRISM/Project CRYPTx
Company: DNAnexus + Boehringer Ingelheim Joint Submission
About the Product:
Together, DNAnexus and Boehringer Ingelheim delivered a secure, cloud-based integration of regulatory workflows connecting DNAnexus’ Trusted Regulatory Spaces, Boehringer’s internal RIM systems, and precisionFDA. The scalable, interoperable platform enables evidence generation, governance, and data exchange through a “submit once, review together” model supporting multi agency reliance and work-sharing. Built-in security, computer system validation, and provenance tracking ensure compliance, data integrity, and reproducibility. By enabling secure collaboration and democratized access to regulatory resources, the platform advances global regulatory stakeholder interaction and efficiency in the cloud.
Sean Connolly
Chief Product & Technology Officer, Evinova
Sean Connolly
Chief Product & Technology Officer, Evinova
Product: Evinova Unified Trial Solution
Company: Evinova
About the Product:
Evinova’s Unified Trial Solution brings the promise of digital health to every patient, everywhere. The platform brings proven clinical, support, and adherence tools into a single, modular app experience that sponsors can configure once and deploy globally - with localization, validation, and app store compliance automated behind the scenes. Multi sponsor architecture, open APIs, and real time analytics power interoperable journeys across trials and therapies, connecting data from eConsent, ePRO/eCOA, reminders, devices, and services. By simplifying access and safeguarding privacy, UTS reduces friction, improves retention and data quality, and shortens time from idea to impact for life changing medicines.
Samantha Xie
Chief Strategy Officer, Future Doctor Inc.
Samantha Xie
Chief Strategy Officer, Future Doctor Inc.
Product: MedGPT - AI Digital Twin of Doctors
Company: Future Doctor Inc.
About the Product:
MedGPT – AI Digital Twin of Doctors MedGPT, developed by Future Doctor Limited., is the world’s first large-scale deployed AI digital twin of physicians, designed to replicate the cognitive processes and workflows of top-tier doctors. Covering the full continuum of care—prevention, diagnosis, treatment, and rehabilitation—MedGPT addresses over 95% of common clinical encounters, reduces treatment costs by up to 86%, and achieves 96% diagnostic concordance with leading physicians from top Chinese hospitals. By enabling a tenfold increase in physician productivity, MedGPT redefines care delivery, improves equity of access, and helps overcome the “impossible triangle” of quality, cost, and efficiency in healthcare.
Ranya Habashv
Chief Medical Officer, Helfie AI
Ranya Habash
Chief Medical Officer, Helfie AI
Product: Helfie AI
Company: Helfie AI
About the Product:
Helfie AI resets the trajectory of health by pairing everyone with their own health AI; checking key conditions, delivering intelligent insights, and enabling persistent monitoring, all via mobile within seconds and for cents. It’s the world’s first early detection health network, accessible to all 8 billion+ humans. Helfie makes early detection the norm, empowering people to take charge of their health, improving life expectancy, and amplifying traditional health systems to be cheaper and smarter. Imagine a future where diseases are caught early, treatments are more effective, and healthcare spending shifts from expensive treatments to cost-effective prevention. That future is Helfie.
Chris Curry
Clinical Director, Women's Health, OURA
Chris Curry
Clinical Director, Women's Health, OURA
Product: Oura Ring 4
Company: Oura
About the Product:
ŌURA is the company behind Oura Ring, the smart ring that delivers personalized health data, insights, and daily guidance on sleep, activity, readiness, and recovery, empowering users to take control of their health and live more balanced lives by providing long-term patterns in their health data and actionable insights.
Avie Luthra
Psychiatrist Consultant, MyPsychAdmin
Avie Luthra
Psychiatrist Consultant, MyPsychAdmin
Product: MPA
Company: MyPsychAdmin
About the Product:
MRIs scan the brain; Dopplers detect clots; colonoscopies hunt the bowel wall. What is the equivalent in Mental Health?
MyPsychAdmin - an app which investigates the ‘body’ of notes, turning 1000s of pages into digestible images and summaries. Using natural language processing, it produces results at approx. 1000 pages/min saving hours of reading. It then feeds this information into letter/report templates, saving hours of writing.
MyPsychAdmin liberates the Mental Health Clinician from Admin by furnishing them with the patient's story accurately and quickly, and by releasing the time and tools needed to empower their patient’s recovery.
Edmund Ben-Ami
CEO, NeuraLight
Edmund Ben-Ami
CEO, NeuraLight
Product: NeuraLight platform
Company: NeuraLight
About the Product:
NeuraLight is a healthtech company transforming neurology with precision biomarkers. The NeuraLight platform addresses the core challenge of accurately monitoring neurological disease progression. Our unprecedentedly accurate biomarkers enable better targeting of underserved patient populations for existing therapies, and facilitate the development of new treatments by de-risking drug trials, increasing their efficiency, and accelerating timelines.
Chrissa McFarlane
Chief Executive Officer, Patientory, Inc.
Chrissa McFarlane
Chief Executive Officer,
Patientory, Inc.
Product: Patientory
Company: Patientory, Inc.
About the Product:
Patientory Digital Health Passport Wallet is a Web3-based, patient-centered platform that empowers individuals to securely manage and share their health data while improving adherence to care plans. The solution integrates with electronic health records, wearables, and remote monitoring tools to provide real-time insights for chronic disease management and population health. With its universal patient identifier and focus on health equity, Patientory supports clinical trial recruitment, care coordination, and social determinants of health tracking—all while maintaining strict data privacy and regulatory compliance. This innovative tool bridges the gap between patients and providers, transforming the delivery of value-based, accessible digital healthcare.
David Stoffel
Chief Business Officer, RapidAI
David Stoffel
Chief Business Officer, RapidAI
Product: iSchemaView Rapid
Company: RapidAI
About the Product:
RapidAI provides cutting-edge medical imaging software that leverages deep clinical AI to enhance decision-making, streamline care team workflows, and ensure that every patient, whether facing stroke, aneurysm, pulmonary embolism, or aortic disease, benefits from advanced technology and clinical expertise.
Zahid Ali Ashraf
Founder & CEO, Techmedo
Zahid Ali Ashraf
Founder & CEO, Techmedo
Product: Healthcare Operating System
Company: Techmedo
About the Product:
Picture a world where healthcare transcends borders and barriers, where care is delivered from the cloud on the ground. This is no distant dream; it's the reality being shaped by TECHMEDO's Healthcare Operating System to deliver Quality primary healthcare for population health. In our hands, we hold the future of healthcare. AI, and data analytics power our system, forging a bridge between tech and care. This Operating System doesn't just amplify healthcare providers; it shakes the very core of traditional care, revolutionizing processes for efficiency and personalization.
Bettina Langemark
CEO, WARD 24/7
Bettina Langemark
CEO, WARD 24/7
Product: WARD Clinical Support System (WARD-CSS)
Company: WARD 24/7
About the Product:
Michelle Davey
CEO, Wheel
Michelle Davey
CEO, Wheel
Product: Wheel Horizon
Company: Wheel
About the Product:
Wheel Horizon™ is a virtual care infrastructure platform purpose-built for life sciences to deliver compliant, scalable, and evidence-based direct-to-patient clinical care and support. With nearly 7 million patient visits to date, Horizon powers longitudinal digital health programs for leading pharma portfolios across preventive, acute, and chronic therapeutic areas. Horizon’s innovative architecture combines a 50-state clinical network, condition-specific protocol library, and integrated pharmacy/lab fulfillment, all while maintaining brand firewalls, clinical independence, and FDA, FTC, and HIPAA compliance. With rapid patient activation, longitudinal engagement, and measurable real-world outcomes, Horizon is setting the new standard for direct-to-patient pharma care and patient support.